EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice

Yutang Wang iD, Owen Sargisson, Dinh Tam Nguyen, Ketura Parker, Stephan J R Pyke, Ahmed Alramahi, Liam Thihlum, Yan Fang, Morgan E Wallace, Stuart P Berzins, Ernesto Oqueli, Dianna J Magliano und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242115955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yutang Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3353, Australia. Hauptthemen laut MEDLINE: Angiotensin II, Aortic Aneurysm, Abdominal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Health and Medical Research Council of Australia, Federation University Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rupture of an abdominal aortic aneurysm (AAA) causes about 200,000 deaths worldwide each year. However, there are currently no effective drug therapies to prevent AAA formation or, when present, to decrease progression and rupture, highlighting an urgent need for more research in this field. Increased vascular inflammation and enhanced apoptosis of vascular smooth muscle cells (VSMCs) are implicated in AAA formation. Here, we investigated whether hydralazine, which has anti-inflammatory and anti-apoptotic properties, inhibited AAA formation and pathological hallmarks. In cultured VSMCs, hydralazine (100 μM) inhibited the increase in inflammatory gene expression and apoptosis induced by acrolein and hydrogen peroxide, two oxidants that may play a role in AAA pathogenesis. The anti-apoptotic effect of hydralazine was associated with a decrease in caspase 8 gene expression. In a mouse model of AAA induced by subcutaneous angiotensin II infusion (1 µg/kg body weight/min) for 28 days in apolipoprotein E-deficient mice, hydralazine treatment (24 mg/kg/day) significantly decreased AAA incidence from 80% to 20% and suprarenal aortic diameter by 32% from 2.26 mm to 1.53 mm. Hydralazine treatment also significantly increased the survival rate from 60% to 100%. In conclusion, hydralazine inhibited AAA formation and rupture in a mouse model, which was associated with its anti-inflammatory and anti-apoptotic properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIAortic Aneurysm, AbdominalAnimalsMiceAnti-Inflammatory AgentsAorta, AbdominalApolipoproteinsApolipoproteins EApoptosisDisease Models, AnimalMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

abdominal aortic aneurysmatherosclerosishydralazineinflammation

Substanzen

Angiotensin IIAnti-Inflammatory AgentsApolipoproteinsApolipoproteins E

Autor:innen und Institutionen

  • Discipline of Life Science, Institute of Innovation, Science and Sustainability, Federation University Australia, Ballarat, VIC 3353, Australia.
  • Cardiology Department, Grampians Health Ballarat, Ballarat, VIC 3350, Australia.
  • School of Medicine, Faculty of Health, Deakin University, Geelong, VIC 3220, Australia.
  • Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.
  • Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, QLD 4811, Australia.
  • Department of Vascular and Endovascular Surgery, The Townsville University Hospital, Townsville, QLD 4811, Australia.

ORCID-Profile: Yutang Wang, Jonathan Golledge

Förderung

  • National Health and Medical Research Council
  • National Health and Medical Research Council of Australia
  • Federation University Australia

Zitieren

APA

Wang, Y., Sargisson, O., Nguyen, D. T., Parker, K., Pyke, S. J. R., Alramahi, A., Thihlum, L., Fang, Y., Wallace, M. E., Berzins, S. P., Oqueli, E., Magliano, D. J., & Golledge, J. (2023). Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115955

Vancouver

Wang Y, Sargisson O, Nguyen DT, Parker K, Pyke SJR, Alramahi A, et al. Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115955

BibTeX
@article{Wang2023,
  author = {Wang, Yutang and Sargisson, Owen and Nguyen, Dinh Tam and Parker, Ketura and Pyke, Stephan J R and Alramahi, Ahmed and Thihlum, Liam and Fang, Yan and Wallace, Morgan E and Berzins, Stuart P and Oqueli, Ernesto and Magliano, Dianna J and Golledge, Jonathan},
  title = {Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242115955}
}
Kostenlos starten →